中文刊名： 《新医药》
英文刊名： Advanced Medicine
国际刊号：
ISSN 3105-6725（印刷版）
ISSN 3105-6733（网络版）
CODEN 码： XYABBJ
（国际标准连续出版物标识符·全球唯一标识符，由美国化学文摘社 CAS 分配）
出版模式： 金色开放获取（Gold OA），遵循知识共享署名 4.0 国际协议（CC BY 4.0），全文永久免费获取
出版机构： Macau Sino-Foreign Medical Publishing Limited
出版频率： 双月刊
出版语言： 中文、英文
投稿语言： 中文（需提供英文标题、摘要、关键词、作者单位及姓名）
发行支持： 国图集团 (CIBTC)
进口备案刊号： G015Z124
本刊已获全球多家权威学术数据库收录，致力于推动高质量研究的全球传播，与全球学者携手，共建开放、协作、前瞻的国际学术共同体。
一、核心定位与愿景
《新医药》是一本聚焦医药创新与临床转化的国际化学术期刊。本刊致力于在基础医学研究、创新药物研发与临床诊疗实践之间构建一座高效、坚实的桥梁，推动前沿科学发现向解决实际临床需求的快速转化。我们高度关注精准医疗、新型疗法（包括细胞治疗、基因治疗等）及转化医学领域的最新突破，特别鼓励融合多学科智慧，采用跨领域交叉的研究范式，为推动全球医药创新体系的发展提供坚实的学术引擎和知识基础。
二、主要征稿方向
本刊长期征集以下领域的原创性、高质量研究论文、综述及方法学探讨：
精准医疗与个体化药物治疗
创新药物设计与开发 (小分子药物、大分子生物药等)
细胞与基因治疗技术
生物制剂与新型疫苗研发
临床前研究与转化医学
创新临床诊疗方案 (含临床试验设计、真实世界研究)
药物递送系统与制剂技术
医学人工智能与数字医疗
罕见病与重大疾病新疗法
药物经济学与医疗政策研究
三、投稿要求
稿件性质：投稿须为原创、未公开发表的学术成果，具备明确的科学创新性或临床转化潜力。
语言要求：稿件正文须以中文撰写。
必备信息：投稿时，请务必完整提供以下中英文对照信息：
文章标题 (中英文)
作者信息：所有作者姓名、所属机构（中英文），以及第一作者/通讯作者简介（含研究方向、电子邮箱）
摘要：中英文结构式摘要，需清晰阐述研究目的、方法、核心发现及主要结论
关键词：3-5个中英文关键词
投稿渠道：请通过本刊官方在线投稿系统提交稿件：http://tg.scionline2025.com/01/
同行评审：本刊实行严格的国际同行双盲评审制度，以确保发表成果的学术质量与严谨性。
四、期刊发展与目标
本刊的愿景是成为中国乃至全球医药创新领域兼具学术权威性与实践影响力的重要期刊。我们致力于打造一个开放、严谨、充满活力的学术共同体，通过促进高水平研究成果的传播与交流，有效链接实验室研究、临床开发与产业应用，为解决全球重大健康挑战、推动人类健康事业的进步贡献知识与智慧。
五、全球数据索引与传播
为最大化研究成果的全球可见度与影响力，本刊正积极推进被以下重要学术数据库收录：
国际核心及专业数据库：Science Citation Index Expanded (SCIE), MEDLINE/PubMed, Scopus, Embase, International Pharmaceutical Abstracts, DOAJ, Google Scholar, ICI World of Journals, EuroPub, EBSCO, Scilit, Scite等。
区域性及中文数据库：中国生物医学文献服务系统、百度学术、万方数据、维普资讯、澳门虚拟图书馆、中国知网 (CNKI)、超星学术平台等。
六、加入我们
我们诚挚邀请全球范围内在基础医学、临床研究、药理学、生物技术及相关领域有深厚造诣的学者专家加入期刊的学术共同体，担任编委、副主编、同行评议专家等职务，共同塑造期刊的未来，提升其国际学术声誉与影响力。欢迎通过以下链接提交申请：
学术职位申请链接： http://tg.scionline2025.com/01/bw.asp






Journal Profile: Advanced Medicine
Chinese Title: 《新医药》
English Title: Advanced Medicine
ISSN:
ISSN 3105-6725 (Print)
ISSN 3105-6733 (Online)
CODEN: XYABBJ (Assigned by Chemical Abstracts Service, CAS)
Publication Model: Gold Open Access under the Creative Commons Attribution 4.0 International License (CC BY 4.0). All articles are permanently and freely accessible online.
Publisher: Macau Sino-Foreign Medical Publishing Limited
Publication Frequency: Bimonthly
Publication Language: Chinese, English
Submission Language: Chinese (English title, abstract, keywords, author affiliations, and names are required)
Distribution Support: China International Book Trading Corporation (CIBTC)
Import Registration Number: G015Z124

1. Core Positioning and Vision
Advanced Medicine is an international academic journal focused on pharmaceutical innovation and clinical translation. The journal is dedicated to building a robust and efficient bridge between fundamental medical research, innovative drug development, and clinical practice, facilitating the rapid translation of cutting-edge scientific discoveries into solutions for unmet clinical needs. We emphasize the latest breakthroughs in precision medicine, novel therapies (including cell and gene therapies), and translational medicine. The journal particularly encourages interdisciplinary research that synthesizes knowledge across multiple fields, serving as a robust academic engine and knowledge foundation to propel the advancement of the global pharmaceutical innovation ecosystem.

2. Main Scope of Submission
The journal invites original, high-quality research articles, reviews, and methodological discussions in, but not limited to, the following areas:

Precision Medicine and Personalized Drug Therapy

Innovative Drug Design and Development (small molecules, biologics, etc.)

Cell and Gene Therapy Technologies

Biologics and Novel Vaccine Development

Preclinical Research and Translational Medicine

Innovative Clinical Diagnosis and Treatment Protocols (including clinical trial design, real-world studies)

Drug Delivery Systems and Formulation Technology

Medical Artificial Intelligence and Digital Health

Novel Therapies for Rare and Major Diseases

Pharmacoeconomics and Healthcare Policy Research

3. Submission Guidelines
Originality: Submissions must be original, unpublished academic work demonstrating clear scientific novelty or clinical translation potential.

Language: Manuscripts must be written in Chinese.

Required Information: Complete bilingual (Chinese and English) information must be provided upon submission, including:

Article Title (Chinese and English)

Author Information: Names and affiliations (in both Chinese and English) of all authors, and a brief biography of the first author/corresponding author (including research interests and email)

Abstract: Structured bilingual abstracts clearly stating the research purpose, methodology, key findings, and main conclusions

Keywords: 3–5 keywords in both Chinese and English

Submission System: Submit via the official online submission system: http://tg.scionline2025.com/01/

Peer Review: The journal employs a rigorous international double-blind peer review system to ensure the academic quality and rigor of published work.

4. Journal Development and Aims
The journal's vision is to become a significant journal in the field of pharmaceutical innovation, recognized both in China and globally for its academic authority and practical influence. We are committed to fostering an open, rigorous, and dynamic scholarly community. By promoting the dissemination and exchange of high-level research outcomes, we aim to effectively connect laboratory research, clinical development, and industrial application, contributing knowledge and wisdom to addressing major global health challenges and advancing human health.

5. Global Indexing and Dissemination
To maximize the global visibility and impact of published research, the journal is actively pursuing inclusion in the following major academic databases:

International Core and Specialized Databases: Science Citation Index Expanded (SCIE), MEDLINE/PubMed, Scopus, Embase, International Pharmaceutical Abstracts, DOAJ, Google Scholar, ICI World of Journals, EuroPub, EBSCO, Scilit, Scite, etc.

Regional and Chinese Databases: SinoMed, Baidu Scholar, WanFang Data, VIP Information, Macau Virtual Library, CNKI (China National Knowledge Infrastructure), Chaoxing Academic Platform, etc.

6. Join Us
We sincerely invite distinguished scholars and experts worldwide in basic medicine, clinical research, pharmacology, biotechnology, and related fields to join our academic community. Applications are welcome for roles such as Editorial Board Member, Associate Editor, and Peer Reviewer to help shape the journal's future and enhance its international academic reputation and impact.
Academic Position Application Link: http://tg.scionline2025.com/01/bw.asp